Galileo Research Facts No. 136: Can Galileo Therapy improve quality of life (QOL) in Fibromyalgia patients?
GRFS, Therapy

Galileo Research Facts No. 136: Can Galileo Therapy improve quality of life (QOL) in Fibromyalgia patients?

This study reported the effects of Galileo Therapy on health related quality of life (HRQOL) in Fibromyalgia patients (12.5Hz, 6x30-60s., 3/week, 12 weeks). Both groups received additional standard therapy, the Galileo group additional Galileo Therapy. While the control groups showed a decrease in health related quality of life (FIQ) by up to 7% the Galileo group showed an improvement with an over-all difference of up to 11%...
Continue reading
Galileo Research Facts No. 112: Can Galileo Therapy improve muscle power and balance in MS patients?
GRFS, Therapy

Galileo Research Facts No. 112: Can Galileo Therapy improve muscle power and balance in MS patients?

This study investigated safety and the effects of Galileo Therapy on muscle power, balance, flexibility and quality of life in MS (Multiple Sclerosis) patients (15-25Hz, pos. 2.5-4.5, 5-8x1min, 3/week, 8weeks, increasing Intensity). The Galileo group showed significant improvements in Balance (+12,8%), Functional Reach Test (+14.2%), muscle power (Timed up and Go, +10%) and FS-36 Mental Health (+9%)...
Continue reading
Galileo Research Facts No. 80: Can Galileo Therapy increase muscle power in Pulmonary Arterial Hypertension (PAH)?
GRFS, Therapy

Galileo Research Facts No. 80: Can Galileo Therapy increase muscle power in Pulmonary Arterial Hypertension (PAH)?

This study documented the effects of 4 weeks of Galileo Therapy on muscle power and quality of life in patients with Pulmonary Arterial Hypertension (PAH) (20Hz, pos. 2, 60 minutes, 4/week, 4 weeks). The control group received standard physio-therapy the Galileo group additional Galileo Therapy. The Galileo Group showed significantly higher increase in muscle power (+12%) and in quality of life assessment (+23%)...
Continue reading